HOXA9 and neoplasm: Reduced cell proliferation, percentage of cells in S phase, and tumor growth/volume, but an enhanced percentage of cells in G0/G1 and an increase in apoptosis was observed in the miR-182 mimic and siRNA-HOXA9 groups compared to the blank, NC, and miR-182 inhibitor + siRNA-HOXA9 groups.